FTO and atrial fibrillation: Second, although both cardiomyocyte‐specific and systemic Fto inhibition effectively improved aging‐related atrial conduction and reduced AF susceptibility, with less atrial fibrosis and dilatation in aging mice, the effects of systemic Fto inhibition on atrial fibrosis and dilatation remained incompletely understood.